Arden Trust’s AbbVie ABBV Stock Holding History

Arden Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$1.17M	Sell	6,819 -16	-0.2%	-$2.65K	0.16%	88
2024 Q1	$1.24M	Sell	6,835 -143	-2%	-$24.6K	0.17%	89
2023 Q4	$1.08M	Sell	6,978 -491	-7%	-$71.6K	0.16%	95
2023 Q3	$1.11M	Sell	7,469 -1,110	-13%	-$163K	0.19%	81
2023 Q2	$1.16M	Sell	8,579 -4,063	-32%	-$596K	0.19%	87
2023 Q1	$2.02M	Sell	12,642 -2,014	-14%	-$308K	0.36%	63
2022 Q4	$2.37M	Sell	14,656 -295	-2%	-$45.2K	0.48%	49
2022 Q3	$2.01M	Buy	14,951 +617	+4%	+$88.5K	0.51%	49
2022 Q2	$2.19M	Buy	+14,334	New	+$2.19M	0.5%	54
2022 Q1	–	Sell	-19,750	Closed	-$2.67M	–	267
2021 Q4	$2.67M	Sell	19,750 -233	-1%	-$27.5K	0.45%	48
2021 Q3	$2.16M	Sell	19,983 -841	-4%	-$96.1K	0.37%	58
2021 Q2	$2.35M	Sell	20,824 -1,931	-8%	-$217K	0.39%	56
2021 Q1	$2.46M	Buy	22,755 +583	+3%	+$62.4K	0.41%	45
2020 Q4	$2.38M	Sell	22,172 -368	-2%	-$35.4K	0.39%	46
2020 Q3	$1.97M	Sell	22,540 -1,136	-5%	-$107K	0.35%	54
2020 Q2	$2.33M	Buy	23,676 +12,662	+115%	+$1.11M	0.43%	46
2020 Q1	$839K	Sell	11,014 -1,364	-11%	-$116K	0.17%	113
2019 Q4	$1.1M	Sell	12,378 -4,660	-27%	-$387K	0.17%	120
2019 Q3	$1.29M	Sell	17,038 -1,896	-10%	-$130K	0.21%	103
2019 Q2	$1.38M	Sell	18,934 -3,344	-15%	-$263K	0.23%	95
2019 Q1	$1.79M	Buy	22,278 +128	+0.6%	+$10.5K	0.29%	68
2018 Q4	$2.04M	Buy	22,150 +215	+1%	+$18.9K	0.37%	52
2018 Q3	$2.07M	Sell	21,935 -1,330	-6%	-$126K	0.32%	57
2018 Q2	$2.15M	Sell	23,265 -2,118	-8%	-$207K	0.34%	57
2018 Q1	$2.4M	Sell	25,383 -3,429	-12%	-$377K	0.37%	48
2017 Q4	$2.79M	Sell	28,812 -825	-3%	-$77.8K	0.42%	46
2017 Q3	$2.63M	Buy	29,637 +1,953	+7%	+$149K	0.4%	50
2017 Q2	$2.01M	Sell	27,684 -1,241	-4%	-$83.4K	0.31%	65
2017 Q1	$1.89M	Sell	28,925 -884	-3%	-$55.6K	0.29%	68
2016 Q4	$1.87M	Buy	29,809 +2,207	+8%	+$135K	0.28%	74
2016 Q3	$1.74M	Sell	27,602 -163,311	-86%	-$10.6M	0.27%	77
2016 Q2	$11.8K	Buy	190,913 +3,608	+2%	+$220K	0.89%	27
2016 Q1	$10.7M	Buy	187,305 +9,333	+5%	+$520K	0.86%	26
2015 Q4	$10.5M	Buy	177,972 +1,652	+0.9%	+$95.2K	0.89%	23
2015 Q3	$9.59M	Buy	176,320 +131,779	+296%	+$8.58M	0.79%	27
2015 Q2	$2.99K	Buy	44,541 +282	+0.6%	+$18.4K	0.45%	55
2015 Q1	$2.59K	Buy	44,259 +20,377	+85%	+$1.23M	0.38%	61
2014 Q4	$1.56M	Sell	23,882 -1,556	-6%	-$98.1K	0.22%	99
2014 Q3	$1.47M	Buy	+25,438	New	+$1.41M	0.2%	101
2014 Q2	–	Sell	-22,447	Closed	-$1.15M	–	320
2014 Q1	$1.15M	Buy	22,447 +5,088	+29%	+$257K	0.14%	131
2013 Q4	$916K	Buy	17,359 +3,715	+27%	+$183K	0.11%	157
2013 Q3	$611K	Sell	13,644 -361	-3%	-$16K	0.08%	202
2013 Q2	$579K	Buy	+14,005	New	+$613K	0.07%	208

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Arden Trust's ABBV Position: Q2 2024 in Review

Arden Trust reduced its AbbVie (ABBV) stake by 0.23% in Q2 2024, selling an estimated $2.65K and leaving 6,819 shares worth $1.17M. The position accounts for 0.16% of the portfolio, ranked #88.

Arden Trust first reported a position in ABBV in Q2 2013 and has held it in 43 quarters since. The position peaked at $10.7M in Q1 2016. 3,364 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

Arden Trust held 6,819 shares of AbbVie worth $1.17M as of Q2 2024.
Arden Trust sold 16 AbbVie shares in Q2 2024, an estimated $2.65K.
AbbVie made up 0.16% of Arden Trust's portfolio in Q2 2024, its #88 holding.
Arden Trust first reported a position in AbbVie in Q2 2013 and has held it in 43 quarters since.
Arden Trust's AbbVie position peaked at $10.7M in Q1 2016.
3,364 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on Arden Trust's 13F filing for Q2 2024, filed 9 Jul 2024.